Upgrade to SI Premium - Free Trial

IDEAYA Biosciences (IDYA)

39.86 -0.11 (0.28%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/10/26)

Latest Headlines

Ideaya Biosciences (IDYA) Reiterated at Market Outperform by Citizens on IDE849 Advances September 1, 2026 4:23 AM - StreetInsider IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) August 28, 2026 6:00 AM - PR NewsWire IDEAYA and Genentech to test drug combo in pancreatic cancer August 19, 2026 6:01 AM - StreetInsider IDEAYA Biosciences Announces Clinical Collaboration with Genentech in MTAP-Deleted KRAS G12D-Mutant Pancreatic Cancer August 19, 2026 6:00 AM - PR NewsWire Form SCHEDULE 13G IDEAYA Biosciences, Inc. Filed by: BAKER BROS. ADVISORS LP August 14, 2026 4:03 PM - SEC Filing Form 10-Q IDEAYA Biosciences, Inc. For: Jun 30 August 4, 2026 4:07 PM - SEC Filing IDEAYA Biosciences (IDYA) Misses Q2 EPS by 16c August 4, 2026 6:19 AM - StreetInsider Form 8-K IDEAYA Biosciences, Inc. For: Aug 04 August 4, 2026 6:05 AM - SEC Filing IDEAYA Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update August 4, 2026 6:00 AM - PR NewsWire Form SCHEDULE 13G IDEAYA Biosciences, Inc. Filed by: VANGUARD CAPITAL MANAGEMENT LLC July 31, 2026 10:18 AM - SEC Filing IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) July 31, 2026 6:00 AM - PR NewsWire IDEAYA Biosciences starts Phase 1/2 expansion for IDE892 in cancer July 27, 2026 6:00 AM - StreetInsider IDEAYA Biosciences Announces IDE892, a Potential Best-in-Class MTA-Cooperative PRMT5 Inhibitor, Initiates Part 2 Monotherapy Expansion in the Phase 1/2 Study in MTAP-Deleted Pancreatic and Lung Cancer July 27, 2026 6:00 AM - PR NewsWire IDEAYA Biosciences Announces ESMO 2026 Presentations for Darovasertib and IDE849 Clinical Programs July 17, 2026 9:00 AM - PR NewsWire Form 4 IDEAYA Biosciences, Inc. For: Jul 07 Filed by: Ruiz Briseno Andres July 9, 2026 4:57 PM - SEC Filing Form 144 IDEAYA Biosciences, Inc. Filed by: Ruiz Briseno Andres July 7, 2026 4:55 PM - SEC Filing Ideaya Biosciences (IDYA) PT Lowered to $48 at RBC Capital July 7, 2026 8:00 AM - StreetInsider Ideaya Biosciences (IDYA) PT Lowered to $63 at Truist Securities July 7, 2026 7:09 AM - StreetInsider IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) June 26, 2026 6:00 AM - PR NewsWire Form 8-K IDEAYA Biosciences, Inc. For: Jun 16 June 23, 2026 4:06 PM - SEC Filing Form 4 IDEAYA Biosciences, Inc. For: Jun 16 Filed by: YARNO WENDY L June 18, 2026 4:34 PM - SEC Filing Form 4 IDEAYA Biosciences, Inc. For: Jun 16 Filed by: Stein Jeffrey June 18, 2026 4:34 PM - SEC Filing Form 4 IDEAYA Biosciences, Inc. For: Jun 16 Filed by: ROSEN TERRY J June 18, 2026 4:33 PM - SEC Filing Form 4 IDEAYA Biosciences, Inc. For: Jun 16 Filed by: Morrison Scott W June 18, 2026 4:33 PM - SEC Filing Form 4 IDEAYA Biosciences, Inc. For: Jun 16 Filed by: MACKEY CATHERINE J June 18, 2026 4:32 PM - SEC Filing Form 4 IDEAYA Biosciences, Inc. For: Jun 16 Filed by: Hampton Malcolm Garret June 18, 2026 4:31 PM - SEC Filing IDEAYA Biosciences names CEO Yujiro Hata as board chairman June 17, 2026 6:01 AM - StreetInsider IDEAYA Biosciences Announces Yujiro S. Hata Elected Chairman of its Board of Directors June 17, 2026 6:00 AM - PR NewsWire IDEAYA starts phase 1/2 trial of IDE892 for pancreatic, lung cancers June 15, 2026 6:00 AM - StreetInsider IDEAYA Biosciences Announces IDE892, a Potential Best-in-Class MTA-Cooperative PRMT5 Inhibitor, Initiates a Phase 1/2 Clinical Combination Study in MTAP-Deleted Pancreatic and Lung Cancers June 15, 2026 6:00 AM - PR NewsWire Form 8-K IDEAYA Biosciences, Inc. For: Jun 08 June 10, 2026 4:10 PM - SEC Filing IDEAYA Biosciences closes $345 million public offering June 10, 2026 4:05 PM - StreetInsider IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares June 10, 2026 4:05 PM - PR NewsWire Form 424B5 IDEAYA Biosciences, Inc. June 9, 2026 5:17 PM - SEC Filing Ideaya Biosciences (IDYA) Reiterated at Market Outperform by Citizens June 9, 2026 4:57 AM - StreetInsider Full Article List